StockData
BioLineRx Ltd. logo

BioLineRx Ltd. (BLRX) stock

BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$1.12−0.03 (-2.61%)

Close on Nov 17, 2026Market cap $4.87MP/E –Yield –

BioLineRx EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was $0.00. The highest annual figure on record is $0.00 in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0.00–
FY2024Dec 31, 2024-$0.01–
FY2023Dec 31, 2023-$0.06–
FY2022Dec 31, 2022-$0.03–
FY2021Dec 31, 2021-$0.04–
FY2020Dec 31, 2020-$0.12–
FY2019Dec 31, 2019-$0.17–
FY2018Dec 31, 2018-$0.21–
FY2017Dec 31, 2017-$0.27–
FY2016Dec 31, 2016-$0.28–
FY2015Dec 31, 2015-$0.28–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0.00–
Q2 FY2025Jun 30, 2025$0.00–
Q2 FY2024Jun 30, 2024$0.00–
Q2 FY2023Jun 30, 2023-$0.02–
Q2 FY2022Jun 30, 2022-$0.01–
Q2 FY2021Jun 30, 2021-$0.01–
Q2 FY2020Jun 30, 2020-$0.03–
Q2 FY2019Jun 30, 2019-$0.04–
Q2 FY2018Jun 30, 2018-$0.05–
Q2 FY2017Jun 30, 2017-$0.05–

More BioLineRx figures

See a number that looks wrong?